Nexentis Technologies Inc. (NXTS)
Develops cancer and inflammatory disease treatments using computational biology and lab screening platforms
$1.44-0.14%Basic Materials
StockGlow Score
Bearish
BearishBullish
1 year ago-97.4%
The outlook
NXTS is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears thin or absent. The stock's current positioning reflects weak near-term momentum and sits at the lower end of its annual range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.1M
52-wk high
$62.97
52-wk low
$1.43
50-day avg
$4.44
200-day avg
$10.65
Trailing P/E
—